U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07475637) titled 'Liquid Biopsy Monitoring Of EGFR T790M in Advanced Non-Small Cell Lung Cancer' on March 05.
Brief Summary: The goal of this retrospective observational study is to assess the clinical utility of plasma-based EGFR testing for detection and longitudinal monitoring of the acquired T790M resistance mutation in patients with advanced EGFR-mutated non-small cell lung cancer (NSCLC) treated with first- or second-generation EGFR tyrosine kinase inhibitors in routine clinical practice in Tunisia.
The main questions it aims to answer are:
* What is the detection rate of EGFR T790M mutation in plasma at the time of disease progression?
* D...